Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 06:30PM GMT
Release Date Price: $50.85
Richard Vosser
JP Morgan Chase & Co, Research Division - Senior Analyst

Good morning. It's my pleasure to welcome Sanofi to the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst. And from Sanofi. I have standing next to me Paul Hudson, the CEO of Sanofi.

Before I hand over to Paul, I'd just remind everybody that the breakout session is in the Borgia Room at the back.

Paul, welcome to the conference.

Paul Hudson
Sanofi - CEO & Director

Thank you. Thank you, Richard. Thank you, everybody, and good morning. Delighted to be here. Delighted to be representing the company.

So the normal comments on forward-looking statements.

Okay. So let's cut to it. So the plan we have at Sanofi is a bold one, it's an exciting one. The work starts now, but the benefits really materialize over 2 phases.

Firstly, and up front, we're refocusing the organization. We're working hard on making some tough decisions. And we're doing that in pursuit of an increased top line performance and increased

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot